TodayBuildContextBrowseMore
stackBETAv0.1
TodayBuild a stackCommon stacksEncyclopediaPulse
Methodology
← Back to your stack
Monograph
RESEARCH GREYS-010
Longevity

Sulforaphane

Isothiocyanate from cruciferous vegetables (broccoli sprouts ~20–50× more concentrated than mature broccoli). Potent NRF2 activator — upregulates ARE (antioxidant response element) genes including HMOX1, NQO1, GSH synthesis. Also inhibits HDAC, suggesting epigenetic anti-cancer activity.

EmergingLongevity
Typical dose10–20 mg/day (from stabilized broccoli sprout extract with myrosinase)
Frequencydaily, oral
Half-life2h
Citations indexed31
DeliveryOral
Half-life~2h
EvidenceEmerging
Citations31
Similar compounds
Synergy checkCompare
Research grey

This compound sits in research-grey territory. The caveats below carry more weight than for FDA-approved entries — read them.

Mechanism

Best human evidence: prostate cancer biomarker suppression (NCT01228084 — sulforaphane reduces PSA kinetics), autism symptom improvement (small RCT, Frye et al. 2015), and air-pollution detoxification (Kensler 2012, China cohort). NRF2 activation is likely the common upstream mechanism across these diverse signals. Stability is critical — sulforaphane degrades rapidly; glucoraphanin + myrosinase (the two-part system in whole broccoli sprout products) is more stable than pre-formed sulforaphane.

Specifics
Sleep quality / depthSlow wound healing
Caveats

Thyroid caution: crucifer-derived compounds can inhibit iodine uptake at high doses (unlikely at typical supplement doses, but flag for hypothyroidism patients). Blood thinner interaction: NRF2 upregulation of CYP450 may alter warfarin metabolism. Product quality highly variable — require products with myrosinase enzyme included.

Evidence levelEmerging
Regulatory statusDietary supplement (DSHEA). Several clinical trials ongoing (NCT IDs for prostate cancer, ASD, air pollution). Not FDA-approved as a drug.
DNA / pharmacogenomicsModerate — GSTT1/GSTM1 null genotypes (common) increase sulforaphane plasma levels and response — higher bioavailability, higher anti-cancer signal.
References

External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.

  • PubMedEN
    RCTAcademic-fundedVerified today
    Alumkal JJ et al. — Sulforaphane prostate cancer trial (Invest New Drugs 2015)
RESEARCH GREYS-010

Dietary supplement (DSHEA). Several clinical trials ongoing (NCT IDs for prostate cancer, ASD, air pollution). Not FDA-approved as a drug.

Can I get it? →
Field reports

Distilled themes from named communities — Reddit threads, forums, creator commentary. Not direct quotes; not clinical evidence. Useful for calibrating expectations against what real self-experimenters report.

r/longevity + Rhonda Patrick community

Rhonda Patrick's broccoli sprout protocol drove significant community adoption. Most users make fresh sprouts (cheapest, highest potency) or use Avmacol. Subjective reports are noisy — hard to isolate from diet improvements that often coincide.

Sulforaphane10–20 mg/day (from stabilized broccoli sprout extract with myrosinase) · daily, oral
Discussion guide, not prescription

stack is an exploration engine. Output is a discussion guide for a conversation with a licensed provider — never a prescription, dose recommendation, or sourcing instruction. Peptides discussed include compounds with limited human evidence and varying legal status by jurisdiction. Verify everything with a qualified clinician before any decision.

Full terms →
stackv0.1
AudiencesWho Stack is forFor researchersFor pharmaciesFor cliniciansFor press
Trust & regulatoryCalibrationMethodologyFDA statusPharmacy registryPCAC commentMX · COFEPRIS
Built honest. Bilingual from day one.